Pharmafile Logo

Do Healthcare Providers Really Want to Go Back to In-person Meetings?

Healthcare professionals (HCPs) are increasingly seeking flexibility and convenience in their interactions with pharmaceutical and life sciences companies. This shift towards digital and blended approaches presents a valuable opportunity for life sciences organizations to enhance their communication and build stronger relationships with HCPs.

- PMLiVE

It is easy to assume that healthcare providers (HCPs) all want to go back to in-person meetings after having been confined to Zoom and Microsoft Teams meetings during the pandemic years. Anecdotally, however, we heard different things: many HCPs highlighted the convenience of the virtual format and considered this a silver lining from the long months of social and physical distancing. In a recent study by our group, the authors sought to understand this. They asked the very important question: what do HCPs really prefer when it comes to Pharma-sponsored small-group meetings such as advisory boards?

Preferred Meeting Format of HCPs

Male healthcare provider (HCP) attending a virtual meetingWhen asked about their preference for future advisory board meetings, a whopping 76% of surveyed HCPs opted for meetings with a virtual component (hybrid, real-time web, and/or asynchronous meetings). Less than a quarter of respondents preferred in-person–only meetings. Interestingly, the most popular meeting approach was found to be a mix of synchronous (real-time) and asynchronous (over-time, anytime) meetings. This finding highlights the importance of using varied formats to cater to all preferences and to avoid digital fatigue.

Another interesting finding was that the preference for hybrid meetings almost doubled between 2022 and 2023, while the preference for in-person–only meetings remained stable. In other words, while many HCPs undoubtedly do still enjoy in-person engagements, giving them the choice of how to attend will help ensure that everyone is happy…

Read the full article here.

 

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Impetus Digital Fireside Chat with Jim Lefevere from Roche

Jim Lefevere from Roche, discusses the changes in digital marketing strategies, workflow, team dynamics, and required skill sets among Pharma teams brought on by COVID-19. We also touch on the slow but...

Patient-Owned Online Marketplace for Patient Insights

Jen Horonjeff, Founder & CEO of Savvy Cooperative, talks about how her personal health journey and experience as a chronic disease patient lead to her founding Savvy Cooperative. We also discuss...

Virtualizing In-person Meetings with the Impetus InSite Platform®

Natalie Yeadon sits down with Mark Corrigan from Impetus Digital to discuss best practices when transferring in-person meetings online.

Train your Brain for Success

Max Newlon, President of Brain Co., discusses everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. We also delve into Brain...

Impetus Digital Fireside Chat With Richie Bavasso From NqMedical

Richie Bavasso, founder and CEO of nQMedical, discusses everything from digital therapeutics, diagnostics, and other data-driven solutions for neurodegenerative diseases to Richie’s favorite media outlets, his work at nQMedical, and lessons learned...

“Fake News” and Credibility in Medical Publishing

Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare.

How Much Does Each Advisor “Insight” Actually Cost?

Even before the concept of physical/social distancing was born, Impetus Digital was a strong advocate for virtual collaboration. In our latest video, we explore another key benefit of asynchronous online...

Virtual Research Grants Submission and Approval Program

Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person.